Odyssey Pharmaceuticals, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

170 documents for Odyssey Pharmaceuticals, Inc.

- Odyssey Pharmaceuticals, Inc. Extends and Expands Strategic Relationship With Dendrite.
Business Editors/Health/Medical Writers MORRISTOWN, N.J.--(BUSINESS WIRE)--May 24, 2004 Growing Pharmaceutical Company Upgrades to Dendrite's WebF...
- Business Wire
- May 24, 2004
- Odyssey Pharmaceuticals, Inc., Names Thomas Wicks to Lead Regulatory Affairs; New addition complements proven management of fast-moving pharmaceutical firm.
EAST HANOVER, N.J. -- Odyssey Pharmaceuticals, Inc., a fast-growing specialty pharmaceutical company, announced today that it will further strengthen ...
- Business Wire
- August 30, 2004
- Zezas begins a space Odyssey.(NEW JERSEY)(Andrew B. Zezas Real Estate Strategies Corp. announces Odyssey Pharmaceuticals Inc.'s disposition of headquarters)(Brief Article)
Andrew B. Zezas, president of Real Estate Strategies Corporation, announced that Odyssey Pharmaceuticals, the U.S. brand name pharmaceuticals division...
- Real Estate Weekly
- July 27, 2005

- Odyssey Pharmaceuticals, Inc. Announces FDA Approval for Custodiol HTK Solution for Perfusion and Flushing of Donor Pancreata, in Addition to Previously Approved Liver, Kidney and Heart Transplants.
FLORHAM PARK, N.J. -- Odyssey Pharmaceuticals, Inc. announced that the FDA has approved an additional indication for the use of Custodiol(R)* HTK Solu...
- Business Wire
- March 29, 2005
- Premanufacture notification waiting periods; early terminations,
...Ritchie..... Application Systems Technology, Inc., Ark River Sand, Inc., Ark River Sand of Oklahoma...20060004............. Odyssey Investment. Residuary Trust under The Fibre-Metal ...20060022............. DAVA Pharmaceuticals, PLIVA d.d........ Odyssey Pharmaceuticals, Inc.....
- FR, November 30, 2005
- Notices
- Federal Trade Commission
- Notice of the Annual Meeting of Stockholders of EpiCept Corporation.
... of the audit committee of Cyberonics, Inc. and Urologix, Inc., both medical device companies... as the interim Chief Executive Officer of Odyssey Pharmaceuticals, Inc., the specialty pharmaceutica...
- Business Wire
- April 30, 2009
- Odyssey Pharmaceuticals and Indevus Pharmaceuticals Announce Odyssey's Plans to Initiate Phase IV Open Label Study of the Effectiveness and Safety of SANCTURA in Patients with Overactive Bladder Symptoms.
...-- Odyssey Pharmaceuticals, Inc. and Indevus Pharmaceuticals, Inc., (NASDAQ: IDEV)...
- Business Wire
- March 15, 2005
- JMP Securities Healthcare Conference to Be Held in New York.
...SAN FRANCISCO -- JMP Group Inc. (NYSE:JMP), an investment banking and alternative...ACADIA Pharmaceuticals Inc. Acceleron Pharma, Inc. Agendia Alexza Pharmac...NeurogesX, Inc. NuVasive, Inc. Odyssey HealthCare, Inc. Optimer Pharmaceuticals, Inc. Ore...
- Business Wire
- September 29, 2009
- PLIVA Signs Deal for Exclusive US Rights to SANCTURA.
... between its specialty branded subsidiary, Odyssey Pharmaceuticals, Inc., and Indevus Pharmaceuticals...
- Business Wire
- April 07, 2004
- Premerger notification waiting periods; early terminations,
...AMVESCAP Retirement, Inc. Inc. Transactions Granted Early Termination--06/0...Allied Capital. Spear Pharmaceuticals, Spear Pharmaceuticals, Corporation. Inc. Inc. 20...Saturn Pharmaceuticals, PLIVA d.d....... Odyssey Inc. Pharmaceuticals. 20051049............... Comp...
- FR, June 29, 2005
- Notices
- Federal Trade Commission